Update on Human Polyomaviruses and Cancer

Advances in Cancer Research

Volumn 106, Issue , 2010, Pages 1-51

  Gjoerup, Ole ^a   Chang, Yuan ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL TRANSFORMATION; HUMAN; MERKEL CELL TUMOR; PHYSIOLOGY; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; REVIEW; SKIN TUMOR; VIROLOGY; VIRUS INFECTION;

ANIMALS; CARCINOMA, MERKEL CELL; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 77954638804     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/S0065-230X(10)06001-X     Document Type: Chapter

References (303)

1. Abend, J.R., Jiang, M., Imperiale, M.J., BK virus and human cancer: innocent until proven guilty. Semin. Cancer Biol. 19 (2009), 252–260.
2. Abend, J.R., Joseph, A.E., Das, D., Campbell-Cecen, D.B., Imperiale, M.J., A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J. Gen. Virol. 90 (2009), 1238–1245.
3. Agelli, M., Clegg, L.X., Epidemiology of primary Merkel cell carcinoma in the United States. J. Am. Acad. Dermatol. 49 (2003), 832–841.
4. Ahuja, D., Saenz-Robles, M.T., Pipas, J.M., SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24 (2005), 7729–7745.
5. Ahuja, D., Rathi, A.V., Greer, A.E., Chen, X.S., Pipas, J.M., A structure-guided mutational analysis of simian virus 40 large T antigen: identification of surface residues required for viral replication and transformation. J. Virol. 83 (2009), 8781–8788.
6. Ali, S.H., Kasper, J.S., Arai, T., DeCaprio, J.A., Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J. Virol. 78 (2004), 2749–2757.
7. Allander, T., Andreasson, K., Gupta, S., Bjerkner, A., Bogdanovic, G., Persson, M.A., Dalianis, T., Ramqvist, T., Andersson, B., Identification of a third human polyomavirus. J. Virol. 81 (2007), 4130–4136.
8. Andrabi, S., Gjoerup, O.V., Kean, J.A., Roberts, T.M., Schaffhausen, B., Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc. Natl. Acad. Sci. USA 104 (2007), 19011–19016.
9. Andres, C., Belloni, B., Puchta, U., Sander, C.A., Flaig, M.J., Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors. J. Cutan. Pathol. 37 (2009), 28–34.
10. Andres, C., Belloni, B., Puchta, U., Sander, C.A., Flaig, M.J., Re: Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J. Natl. Cancer Inst. 101 (2009), 1655–1656 (Author reply 1656–7).
11. Arroyo, J.D., Hahn, W.C., Involvement of PP2A in viral and cellular transformation. Oncogene 24 (2005), 7746–7755.
12. Atkin, S.J., Griffin, B.E., Dilworth, S.M., Polyoma virus and simian virus 40 as cancer models: history and perspectives. Semin. Cancer Biol. 19 (2009), 211–217.
13. Babakir-Mina, M., Ciccozzi, M., Alteri, C., Polchi, P., Picardi, A., Greco, F., Lucarelli, G., Arcese, W., Perno, C.F., Ciotti, M., Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J. Med. Virol. 81 (2009), 1668–1673.
14. Babakir-Mina, M., Ciccozzi, M., Bonifacio, D., Bergallo, M., Costa, C., Cavallo, R., Di Bonito, L., Perno, C.F., Ciotti, M., Identification of the novel KI and WU polyomaviruses in human tonsils. J. Clin. Virol. 46 (2009), 75–79.
15. Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K., Vogelstein, B., Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (1990), 912–915.
16. Barbeau, D., Charbonneau, R., Whalen, S.G., Bayley, S.T., Branton, P.E., Functional interactions within adenovirus E1A protein complexes. Oncogene 9 (1994), 359–373.
17. Bargonetti, J., Reynisdottir, I., Friedman, P.N., Prives, C., Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6 (1992), 1886–1898.
18. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., Takaoka, M., Nakagawa, H., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006), 633–637.
19. Beachy, T.M., Cole, S.L., Cavender, J.F., Tevethia, M.J., Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts. J. Virol. 76 (2002), 3145–3157.
20. Becker, J.C., Houben, R., Ugurel, S., Trefzer, U., Pfohler, C., Schrama, D., MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J. Invest. Dermatol. 129 (2009), 248–250.
21. Behzad-Behbahani, A., Klapper, P.E., Vallely, P.J., Cleator, G.M., Khoo, S.H., Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J. Clin. Virol. 29 (2004), 224–229.
22. Bennoun, M., Grimber, G., Couton, D., Seye, A., Molina, T., Briand, P., Joulin, V., The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice. Oncogene 17 (1998), 1253–1259.
23. Berk, A.J., Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24 (2005), 7673–7685.
24. Bhatia, K., Modali, R., Goedert, J.J., Merkel cell polyomavirus is not detected in mesotheliomas. J. Clin. Virol. 47 (2008), 196–198.
25. Bialasiewicz, S., Whiley, D.M., Lambert, S.B., Jacob, K., Bletchly, C., Wang, D., Nissen, M.D., Sloots, T.P., Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection. J. Clin. Virol. 41 (2008), 63–68.
26. Bialasiewicz, S., Lambert, S.B., Whiley, D.M., Nissen, M.D., Sloots, T.P., Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg. Infect. Dis. 15 (2009), 492–494.
27. Bikel, I., Mamon, H., Brown, E.L., Boltax, J., Agha, M., Livingston, D.M., The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen. Mol. Cell. Biol. 6 (1986), 1172–1178.
28. Bluemn, E.G., Paulson, K.G., Higgins, E.E., Sun, Y., Nghiem, P., Nelson, P.S., Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls. J. Clin. Virol. 44 (2009), 164–166.
29. Bocchetta, M., Eliasz, S., De Marco, M.A., Rudzinski, J., Zhang, L., Carbone, M., The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res. 68 (2008), 1022–1029.
30. Bofill-Mas, S., Girones, R., Role of the environment in the transmission of JC virus. J. Neurovirol. 9:Suppl. 1 (2003), 54–58.
31. Bofill-Mas, S., Pina, S., Girones, R., Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl. Environ. Microbiol. 66 (2000), 238–245.
32. Bonvoisin, C., Weekers, L., Xhignesse, P., Grosch, S., Milicevic, M., Krzesinski, J.M., Polyomavirus in renal transplantation: a hot problem. Transplantation 85 (2008), S42–S48.
33. Borger, D.R., DeCaprio, J.A., Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. J. Virol. 80 (2006), 4292–4303.
34. Bouck, N., Beales, N., Shenk, T., Berg, P., di Mayorca, G., New region of the simian virus 40 genome required for efficient viral transformation. Proc. Natl. Acad. Sci. USA 75 (1978), 2473–2477.
35. Boyapati, A., Wilson, M., Yu, J., Rundell, K., SV40 17KT antigen complements dnaj mutations in large T antigen to restore transformation of primary human fibroblasts. Virology 315 (2003), 148–158.
36. Brade, L., Muller-Lantzsch, N., zur Hausen, H., B-lymphotropic papovavirus and possibility of infections in humans. J. Med. Virol. 6 (1981), 301–308.
37. Brinster, R.L., Chen, H.Y., Messing, A., van Dyke, T., Levine, A.J., Palmiter, R.D., Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37 (1984), 367–379.
38. Brosh, R., Rotter, V., When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9 (2009), 701–713.
39. Burkhart, D.L., Sage, J., Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 8 (2008), 671–682.
40. Busam, K.J., Jungbluth, A.A., Rekthman, N., Coit, D., Pulitzer, M., Bini, J., Arora, R., Hanson, N.C., Tassello, J.A., Frosina, D., Moore, P., Chang, Y., Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am. J. Surg. Pathol. 33 (2009), 1378–1385.
41. Cahill, D.P., Lengauer, C., Yu, J., Riggins, G.J., Willson, J.K., Markowitz, S.D., Kinzler, K.W., Vogelstein, B., Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998), 300–303.
42. Campbell, K.S., Mullane, K.P., Aksoy, I.A., Stubdal, H., Zalvide, J., Pipas, J.M., Silver, P.A., Roberts, T.M., Schaffhausen, B.S., DeCaprio, J.A., DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev. 11 (1997), 1098–1110.
43. Carter, J.J., Paulson, K.G., Wipf, G.C., Miranda, D., Madeleine, M.M., Johnson, L.G., Lemos, B.D., Lee, S., Warcola, A.H., Iyer, J.G., Nghiem, P., Galloway, D.A., Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J. Natl. Cancer Inst. 101 (2009), 1510–1522.
44. Chan, H.M., Narita, M., Lowe, S.W., Livingston, D.M., The p400 E1A-associated protein is a novel component of the p53 → p21 senescence pathway. Genes Dev. 19 (2005), 196–201.
45. Chang, L.S., Pan, S., Pater, M.M., Di Mayorca, G., Differential requirement for SV40 early genes in immortalization and transformation of primary rat and human embryonic cells. Virology 146 (1985), 246–261.
46. Chang, T.H., Ray, F.A., Thompson, D.A., Schlegel, R., Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene 14 (1997), 2383–2393.
47. Cheetham, M.E., Brion, J.P., Anderton, B.H., Human homologues of the bacterial heat-shock protein DnaJ are preferentially expressed in neurons. Biochem. J. 284:Pt 2 (1992), 469–476.
48. Chen, S., Paucha, E., Identification of a region of simian virus 40 large T antigen required for cell transformation. J. Virol. 64 (1990), 3350–3357.
49. Chen, J., Tobin, G.J., Pipas, J.M., Van Dyke, T., T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. Oncogene 7 (1992), 1167–1175.
50. Chen, W., Possemato, R., Campbell, K.T., Plattner, C.A., Pallas, D.C., Hahn, W.C., Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5 (2004), 127–136.
51. Chen, Y., Xu, Y., Bao, Q., Xing, Y., Li, Z., Lin, Z., Stock, J.B., Jeffrey, P.D., Shi, Y., Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40. Nat. Struct. Mol. Biol. 14 (2007), 527–534.
52. Chen, Y., Bord, E., Tompkins, T., Miller, J., Tan, C.S., Kinkel, R.P., Stein, M.C., Viscidi, R.P., Ngo, L.H., Koralnik, I.J., Asymptomatic reactivation of JC virus in patients treated with natalizumab. N. Engl. J. Med. 361 (2009), 1067–1074.
53. Cheng, J., DeCaprio, J.A., Fluck, M.M., Schaffhausen, B.S., Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens. Semin. Cancer Biol. 19 (2009), 218–228.
54. Cho, U.S., Morrone, S., Sablina, A.A., Arroyo, J.D., Hahn, W.C., Xu, W., Structural basis of PP2A inhibition by small t antigen. PLoS Biol., 5, 2007, e202.
55. Cicala, C., Avantaggiati, M.L., Graessmann, A., Rundell, K., Levine, A.S., Carbone, M., Simian virus 40 small-t antigen stimulates viral DNA replication in permissive monkey cells. J. Virol. 68 (1994), 3138–3144.
56. Cimbaluk, D., Pitelka, L., Kluskens, L., Gattuso, P., Update on human polyomavirus BK nephropathy. Diagn. Cytopathol. 37 (2009), 773–779.
57. Cotsiki, M., Lock, R.L., Cheng, Y., Williams, G.L., Zhao, J., Perera, D., Freire, R., Entwistle, A., Golemis, E.A., Roberts, T.M., Jat, P.S., Gjoerup, O.V., Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc. Natl. Acad. Sci. USA 101 (2004), 947–952.
58. Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R.L., Lansdorp, P.M., Sedivy, J.M., Weinberg, R.A., Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95 (1998), 14723–14728.
59. Dahl, J., You, J., Benjamin, T.L., Induction and utilization of an ATM signaling pathway by polyomavirus. J. Virol. 79 (2005), 13007–13017.
60. D'Ambrosio, C., Keller, S.R., Morrione, A., Lienhard, G.E., Baserga, R., Surmacz, E., Transforming potential of the insulin receptor substrate 1. Cell Growth Differ. 6 (1995), 557–562.
61. Daniels, R., Sadowicz, D., Hebert, D.N., A very late viral protein triggers the lytic release of SV40. PLoS Pathog., 3, 2007, e98.
62. Dannenberg, J.H., van Rossum, A., Schuijff, L., te Riele, H., Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14 (2000), 3051–3064.
63. DeAngelis, T., Chen, J., Wu, A., Prisco, M., Baserga, R., Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling. Oncogene 25 (2006), 32–42.
64. DeCaprio, J.A., How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. Virology 384 (2009), 274–284.
65. DeCaprio, J.A., Ludlow, J.W., Figge, J., Shew, J.Y., Huang, C.M., Lee, W.H., Marsilio, E., Paucha, E., Livingston, D.M., SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54 (1988), 275–283.
66. Deppert, W., Haug, M., Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells. Mol. Cell. Biol. 6 (1986), 2233–2240.
67. Deppert, W., Steinmayer, T., Richter, W., Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation. Oncogene 4 (1989), 1103–1110.
68. de Ronde, A., Sol, C.J., van Strien, A., ter Schegget, J., van der Noordaa, J., The SV40 small t antigen is essential for the morphological transformation of human fibroblasts. Virology 171 (1989), 260–263.
69. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre, M., Nuciforo, P.G., Bensimon, A., Maestro, R., Pelicci, P.G., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 (2006), 638–642.
70. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A.K., Moore, M., Finlay, C., Levine, A.J., Gain of function mutations in p53. Nat. Genet. 4 (1993), 42–46.
71. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A. Jr., Butel, J.S., Bradley, A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992), 215–221.
72. Drews, K., Bashir, T., Dorries, K., Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR. J. Virol. Methods 84 (2000), 23–36.
73. Duncavage, E.J., Le, B.M., Wang, D., Pfeifer, J.D., Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am. J. Surg. Pathol. 33 (2009), 1771–1777.
74. Duncavage, E.J., Zehnbauer, B.A., Pfeifer, J.D., Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod. Pathol. 22 (2009), 516–521.
75. Dyson, N., Howley, P.M., Munger, K., Harlow, E., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989), 934–937.
76. Eash, S., Manley, K., Gasparovic, M., Querbes, W., Atwood, W.J., The human polyomaviruses. Cell. Mol. Life Sci. 63 (2006), 865–876.
77. Eckner, R., Ludlow, J.W., Lill, N.L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J.A., Livingston, D.M., Morgan, J.A., Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16 (1996), 3454–3464.
78. Eddy, B.E., Borman, G.S., Grubbs, G.E., Young, R.D., Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40. Virology 17 (1962), 65–75.
79. Egan, C., Jelsma, T.N., Howe, J.A., Bayley, S.T., Ferguson, B., Branton, P.E., Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol. Cell. Biol. 8 (1988), 3955–3959.
80. Egli, A., Infanti, L., Dumoulin, A., Buser, A., Samaridis, J., Stebler, C., Gosert, R., Hirsch, H.H., Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 199 (2009), 837–846.
81. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993), 817–825.
82. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., Oren, M., Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86 (1989), 8763–8767.
83. Elphick, G.F., Querbes, W., Jordan, J.A., Gee, G.V., Eash, S., Manley, K., Dugan, A., Stanifer, M., Bhatnagar, A., Kroeze, W.K., Roth, B.L., Atwood, W.J., The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306 (2004), 1380–1383.
84. Engels, E.A., Frisch, M., Goedert, J.J., Biggar, R.J., Miller, R.W., Merkel cell carcinoma and HIV infection. Lancet 359 (2002), 497–498.
85. Erickson, K.D., Garcea, R.L., Tsai, B., Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus. J. Virol. 83 (2009), 10275–10279.
86. Ewald, D., Li, M., Efrat, S., Auer, G., Wall, R.J., Furth, P.A., Hennighausen, L., Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273 (1996), 1384–1386.
87. Fanning, E., Knippers, R., Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61 (1992), 55–85.
88. Fei, Z.L., D'Ambrosio, C., Li, S., Surmacz, E., Baserga, R., Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell. Biol. 15 (1995), 4232–4239.
89. Feng, H., Taylor, J.L., Benos, P.V., Newton, R., Waddell, K., Lucas, S.B., Chang, Y., Moore, P.S., Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J. Virol. 81 (2007), 11332–11340.
90. Feng, H., Shuda, M., Chang, Y., Moore, P.S., Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008), 1096–1100.
91. Ferrari, R., Pellegrini, M., Horwitz, G.A., Xie, W., Berk, A.J., Kurdistani, S.K., Epigenetic reprogramming by adenovirus e1a. Science 321 (2008), 1086–1088.
92. Finlay, C.A., Hinds, P.W., Levine, A.J., The p53 proto-oncogene can act as a suppressor of transformation. Cell 57 (1989), 1083–1093.
93. Foulongne, V., Dereure, O., Kluger, N., Moles, J.P., Guillot, B., Segondy, M., Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br. J. Dermatol. 162 (2009), 59–63.
94. Friedrich, T.D., Laffin, J., Lehman, J.M., Simian virus 40 large T-antigen function is required for induction of tetraploid DNA content during lytic infection. J. Virol. 66 (1992), 4576–4579.
95. Fuchs, M., Gerber, J., Drapkin, R., Sif, S., Ikura, T., Ogryzko, V., Lane, W.S., Nakatani, Y., Livingston, D.M., The p400 complex is an essential E1A transformation target. Cell 106 (2001), 297–307.
96. Gaillard, S., Fahrbach, K.M., Parkati, R., Rundell, K., Overexpression of simian virus 40 small-T antigen blocks centrosome function and mitotic progression in human fibroblasts. J. Virol. 75 (2001), 9799–9807.
97. Gardner, S.D., Field, A.M., Coleman, D.V., Hulme, B., New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1 (1971), 1253–1257.
98. Garneski, K.M., Warcola, A.H., Feng, Q., Kiviat, N.B., Leonard, J.H., Nghiem, P., Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J. Invest. Dermatol. 129 (2009), 246–248.
99. Gaynor, A.M., Nissen, M.D., Whiley, D.M., Mackay, I.M., Lambert, S.B., Wu, G., Brennan, D.C., Storch, G.A., Sloots, T.P., Wang, D., Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog., 3, 2007, e64.
100. Gayther, S.A., Batley, S.J., Linger, L., Bannister, A., Thorpe, K., Chin, S.F., Daigo, Y., Russell, P., Wilson, A., Sowter, H.M., Delhanty, J.D., Ponder, B.A., et al. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24 (2000), 300–303.
101. Gjoerup, O., Chao, H., DeCaprio, J.A., Roberts, T.M., pRB-dependent, J domain-independent function of simian virus 40 large T antigen in override of p53 growth suppression. J. Virol. 74 (2000), 864–874.
102. Gjoerup, O.V., Wu, J., Chandler-Militello, D., Williams, G.L., Zhao, J., Schaffhausen, B., Jat, P.S., Roberts, T.M., Surveillance mechanism linking Bub1 loss to the p53 pathway. Proc. Natl. Acad. Sci. USA 104 (2007), 8334–8339.
103. Goh, S., Lindau, C., Tiveljung-Lindell, A., Allander, T., Merkel cell polyomavirus in respiratory tract secretions. Emerg. Infect. Dis. 15 (2009), 489–491.
104. Goodman, R.H., Smolik, S., CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000), 1553–1577.
105. Greenberg, N.M., DeMayo, F., Finegold, M.J., Medina, D., Tilley, W.D., Aspinall, J.O., Cunha, G.R., Donjacour, A.A., Matusik, R.J., Rosen, J.M., Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92 (1995), 3439–3443.
106. Gross, L., A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 83 (1953), 414–421.
107. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W., Weinberg, R.A., Creation of human tumour cells with defined genetic elements. Nature 400 (1999), 464–468.
108. Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini, D.M., DeCaprio, J.A., Weinberg, R.A., Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22 (2002), 2111–2123.
109. Hauft, S.M., Kim, S.H., Schmidt, G.H., Pease, S., Rees, S., Harris, S., Roth, K.A., Hansbrough, J.R., Cohn, S.M., Ahnen, D.J., et al. Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect on cellular differentiation programs and does not cause neoplastic transformation. J. Cell. Biol. 117 (1992), 825–839.
110. Hein, J., Boichuk, S., Wu, J., Cheng, Y., Freire, R., Jat, P.S., Roberts, T.M., Gjoerup, O.V., Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J. Virol. 83 (2009), 117–127.
111. Hermannstadter, A., Ziegler, C., Kuhl, M., Deppert, W., Tolstonog, G.V., Wild-type p53 enhances efficiency of Simian virus 40 large T-antigen induced cellular transformation. J. Virol. 83 (2009), 10106–10118.
112. Herzig, M., Novatchkova, M., Christofori, G., An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis. Biol. Chem. 380 (1999), 203–211.
113. Hill, R., Song, Y., Cardiff, R.D., Van Dyke, T., Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. Cancer Res. 65 (2005), 10243–10254.
114. Hodgson, N.C., Merkel cell carcinoma: changing incidence trends. J. Surg. Oncol. 89 (2005), 1–4.
115. Hollstein, M., Rice, K., Greenblatt, M.S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R., Harris, C.C., Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22 (1994), 3551–3555.
116. Horwitz, G.A., Zhang, K., McBrian, M.A., Grunstein, M., Kurdistani, S.K., Berk, A.J., Adenovirus small e1a alters global patterns of histone modification. Science 321 (2008), 1084–1085.
117. Howe, J.A., Mymryk, J.S., Egan, C., Branton, P.E., Bayley, S.T., Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc. Natl. Acad. Sci. USA 87 (1990), 5883–5887.
118. Howe, A.K., Gaillard, S., Bennett, J.S., Rundell, K., Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors. J. Virol. 72 (1998), 9637–9644.
119. Huber, C., Dias-Santagata, D., Glaser, A., O'Sullivan, J., Brauner, R., Wu, K., Xu, X., Pearce, K., Wang, R., Uzielli, M.L., Dagoneau, N., Chemaitilly, W., et al. Identification of mutations in CUL7 in 3-M syndrome. Nat. Genet. 37 (2005), 1119–1124.
120. Huebner, K., Santoli, D., Croce, C.M., Koprowski, H., Characterization of defective SV40 isolated from SV40-transformed cells. Virology 63 (1975), 512–522.
121. Iyer, N.G., Ozdag, H., Caldas, C., p300/CBP and cancer. Oncogene 23 (2004), 4225–4231.
122. Jeffers, L.K., Madden, V., Webster-Cyriaque, J., BK virus has tropism for human salivary gland cells in vitro: implications for transmission. Virology 394 (2009), 183–193.
123. Jeganathan, K., Malureanu, L., Baker, D.J., Abraham, S.C., van Deursen, J.M., Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J. Cell. Biol. 179 (2007), 255–267.
124. Jiang, D., Srinivasan, A., Lozano, G., Robbins, P.D., SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8 (1993), 2805–2812.
125. Jog, P., Joshi, B., Dhamankar, V., Imperiale, M.J., Rutila, J., Rundell, K., Mutational analysis of simian virus 40 small-t antigen. J. Virol. 64 (1990), 2895–2900.
126. Kalderon, D., Smith, A.E., In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Virology 139 (1984), 109–137.
127. Kantola, K., Sadeghi, M., Lahtinen, A., Koskenvuo, M., Aaltonen, L.M., Mottonen, M., Rahiala, J., Saarinen-Pihkala, U., Riikonen, P., Jartti, T., Ruuskanen, O., Soderlund-Venermo, M., et al. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J. Clin. Virol. 45 (2009), 292–295.
128. Kasper, J.S., Kuwabara, H., Arai, T., Ali, S.H., DeCaprio, J.A., Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J. Virol. 79 (2005), 11685–11692.
129. Kassem, A., Schopflin, A., Diaz, C., Weyers, W., Stickeler, E., Werner, M., Zur Hausen, A., Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 68 (2008), 5009–5013.
130. Kassem, A., Technau, K., Kurz, A.K., Pantulu, D., Loning, M., Kayser, G., Stickeler, E., Weyers, W., Diaz, C., Werner, M., Nashan, D., Zur Hausen, A., Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int. J. Cancer. 125 (2009), 356–361.
131. Katano, H., Ito, H., Suzuki, Y., Nakamura, T., Sato, Y., Tsuji, T., Matsuo, K., Nakagawa, H., Sata, T., Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma. J. Med. Virol. 81 (2009), 1951–1958.
132. Kean, J.M., Rao, S., Wang, M., Garcea, R.L., Seroepidemiology of human polyomaviruses. PLoS Pathog., 5, 2009, e1000363.
133. Kelley, W.L., Landry, S.J., Chaperone power in a virus?. Trends Biochem. Sci. 19 (1994), 277–278.
134. Khalili, K., White, M.K., Sawa, H., Nagashima, K., Safak, M., The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J. Cell. Physiol. 204 (2005), 1–7.
135. Kierstead, T.D., Tevethia, M.J., Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 67 (1993), 1817–1829.
136. Kim, S.H., Roth, K.A., Moser, A.R., Gordon, J.I., Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J. Cell. Biol. 123 (1993), 877–893.
137. Kim, S.H., Roth, K.A., Coopersmith, C.M., Pipas, J.M., Gordon, J.I., Expression of wild-type and mutant simian virus 40 large tumor antigens in villus-associated enterocytes of transgenic mice. Proc. Natl. Acad. Sci. USA 91 (1994), 6914–6918.
138. Kim, H.Y., Ahn, B.Y., Cho, Y., Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J. 20 (2001), 295–304.
139. Kleinschmidt-DeMasters, B.K., Tyler, K.L., Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353 (2005), 369–374.
140. Knowles, W.A., Pipkin, P., Andrews, N., Vyse, A., Minor, P., Brown, D.W., Miller, E., Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71 (2003), 115–123.
141. Knudson, A.G. Jr., Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68 (1971), 820–823.
142. Kohrman, D.C., Imperiale, M.J., Simian virus 40 large T antigen stably complexes with a 185-kilodalton host protein. J. Virol. 66 (1992), 1752–1760.
143. Krynska, B., Del Valle, L., Croul, S., Gordon, J., Katsetos, C.D., Carbone, M., Giordano, A., Khalili, K., Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc. Natl. Acad. Sci. USA 96 (1999), 11519–11524.
144. Kwun, H.J., Guastafierro, A., Shuda, M., Meinke, G., Bohm, A., Moore, P.S., Chang, Y., The minimum replication origin of Merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J. Virol. 83 (2009), 12118–12128.
145. Lane, D.P., Cancer. p53, guardian of the genome. Nature 358 (1992), 15–16.
146. Lane, D.P., Crawford, L.V., T antigen is bound to a host protein in SV40-transformed cells. Nature 278 (1979), 261–263.
147. Langer-Gould, A., Atlas, S.W., Green, A.J., Bollen, A.W., Pelletier, D., Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353 (2005), 375–381.
148. Lee, J.H., Paull, T.T., ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308 (2005), 551–554.
149. Lee, W.H., Bookstein, R., Hong, F., Young, L.J., Shew, J.Y., Lee, E.Y., Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235 (1987), 1394–1399.
150. Levine, A.J., Oren, M., The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9 (2009), 749–758.
151. Levine, D.S., Sanchez, C.A., Rabinovitch, P.S., Reid, B.J., Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc. Natl. Acad. Sci. USA 88 (1991), 6427–6431.
152. Li, D., Zhao, R., Lilyestrom, W., Gai, D., Zhang, R., DeCaprio, J.A., Fanning, E., Jochimiak, A., Szakonyi, G., Chen, X.S., Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen. Nature 423 (2003), 512–518.
153. Lill, N.L., Tevethia, M.J., Eckner, R., Livingston, D.M., Modjtahedi, N., p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 71 (1997), 129–137.
154. Lilyestrom, W., Klein, M.G., Zhang, R., Joachimiak, A., Chen, X.S., Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20 (2006), 2373–2382.
155. Lin, J.Y., Simmons, D.T., The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. J. Virol. 65 (1991), 6447–6453.
156. Linzer, D.I., Levine, A.J., Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17 (1979), 43–52.
157. Loeken, M., Bikel, I., Livingston, D.M., Brady, J., Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen. Cell 55 (1988), 1171–1177.
158. Low, J.A., Magnuson, B., Tsai, B., Imperiale, M.J., Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 80 (2006), 1361–1366.
159. Loyo, M., Guerrero-Preston, R., Brait, M., Hoque, M., Chuang, A., Kim, M., Sharma, R., Liegeois, N., Koch, W., Califano, J., Westra, W., Sidransky, D., Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int. J. Cancer, 2009 [Epub ahead of print].
160. Luo, X., Sanford, D.G., Bullock, P.A., Bachovchin, W.W., Solution structure of the origin DNA-binding domain of SV40 T-antigen. Nat. Struct. Biol. 3 (1996), 1034–1039.
161. Maginnis, M.S., Atwood, W.J., JC virus: an oncogenic virus in animals and humans?. Semin. Cancer Biol. 19 (2009), 261–269.
162. Major, E.O., Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies. Annu. Rev. Med. 61 (2010), 35–47.
163. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F. Jr., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 (1990), 1233–1238.
164. Manfredi, J.J., Prives, C., The transforming activity of simian virus 40 large tumor antigen. Biochim. Biophys. Acta 1198 (1994), 65–83.
165. Maricich, S.M., Wellnitz, S.A., Nelson, A.M., Lesniak, D.R., Gerling, G.J., Lumpkin, E.A., Zoghbi, H.Y., Merkel cells are essential for light-touch responses. Science 324 (2009), 1580–1582.
166. Marin, M.C., Jost, C.A., Irwin, M.S., DeCaprio, J.A., Caput, D., Kaelin, W.G. Jr., Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol. 18 (1998), 6316–6324.
167. Markovics, J.A., Carroll, P.A., Robles, M.T., Pope, H., Coopersmith, C.M., Pipas, J.M., Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53. J. Virol. 79 (2005), 7492–7502.
168. Marsilio, E., Cheng, S.H., Schaffhausen, B., Paucha, E., Livingston, D.M., The T/t common region of simian virus 40 large T antigen contains a distinct transformation-governing sequence. J. Virol. 65 (1991), 5647–5652.
169. Masumori, N., Thomas, T.Z., Chaurand, P., Case, T., Paul, M., Kasper, S., Caprioli, R.M., Tsukamoto, T., Shappell, S.B., Matusik, R.J., A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res. 61 (2001), 2239–2249.
170. McQuaig, S.M., Scott, T.M., Harwood, V.J., Farrah, S.R., Lukasik, J.O., Detection of human-derived fecal pollution in environmental waters by use of a PCR-based human polyomavirus assay. Appl. Environ. Microbiol. 72 (2006), 7567–7574.
171. Meinke, G., Phelan, P., Moine, S., Bochkareva, E., Bochkarev, A., Bullock, P.A., Bohm, A., The crystal structure of the SV40 T-antigen origin binding domain in complex with DNA. PLoS Biol., 5, 2007, e23.
172. Meraldi, P., Sorger, P.K., A dual role for Bub1 in the spindle checkpoint and chromosome congression. EMBO J. 24 (2005), 1621–1633.
173. Mertz, K.D., Junt, T., Schmid, M., Pfaltz, M., Kempf, W., Inflammatory monocytes are a reservoir for Merkel cell polyomavirus. J. Invest. Dermatol. 130 (2009), 1146–1151.
174. Mietz, J.A., Unger, T., Huibregtse, J.M., Howley, P.M., The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11 (1992), 5013–5020.
175. Millward, T.A., Zolnierowicz, S., Hemmings, B.A., Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24 (1999), 186–191.
176. Monaco, M.C., Jensen, P.N., Hou, J., Durham, L.C., Major, E.O., Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J. Virol. 72 (1998), 9918–9923.
177. Monaco, M.C., Shin, J., Major, E.O., JC virus infection in cells from lymphoid tissue. Dev. Biol. Stand. 94 (1998), 115–122.
178. Montano, X., Millikan, R., Milhaven, J.M., Newsom, D.A., Ludlow, J.W., Arthur, A.K., Fanning, E., Bikel, I., Livingston, D.M., Simian virus 40 small tumor antigen and an amino-terminal domain of large tumor antigen share a common transforming function. Proc. Natl. Acad. Sci. USA 87 (1990), 7448–7452.
179. Moreno, C.S., Ramachandran, S., Ashby, D.G., Laycock, N., Plattner, C.A., Chen, W., Hahn, W.C., Pallas, D.C., Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown. Cancer Res. 64 (2004), 6978–6988.
180. Morris, E.J., Dyson, N.J., Retinoblastoma protein partners. Adv. Cancer Res. 82 (2001), 1–54.
181. Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E., Howley, P.M., Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8 (1989), 4099–4105.
182. Mungre, S., Enderle, K., Turk, B., Porras, A., Wu, Y.Q., Mumby, M.C., Rundell, K., Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J. Virol. 68 (1994), 1675–1681.
183. Neufeld, D.S., Ripley, S., Henderson, A., Ozer, H.L., Immortalization of human fibroblasts transformed by origin-defective simian virus 40. Mol. Cell. Biol. 7 (1987), 2794–2802.
184. Nevels, M., Rubenwolf, S., Spruss, T., Wolf, H., Dobner, T., The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc. Natl. Acad. Sci. USA 94 (1997), 1206–1211.
185. Ng, S.C., Mertz, J.E., Sanden-Will, S., Bina, M., Simian virus 40 maturation in cells harboring mutants deleted in the agnogene. J. Biol. Chem. 260 (1985), 1127–1132.
186. Norja, P., Ubillos, I., Templeton, K., Simmonds, P., No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J. Clin. Virol. 40 (2007), 307–311.
187. Nunbhakdi-Craig, V., Craig, L., Machleidt, T., Sontag, E., Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J. Virol. 77 (2003), 2807–2818.
188. O'Donnell, P.H., Swanson, K., Josephson, M.A., Artz, A.S., Parsad, S.D., Ramaprasad, C., Pursell, K., Rich, E., Stock, W., van Besien, K., BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biol. Blood Marrow. Transplant. 15 (2009), 1038–1048 e1.
189. Oren, M., Maltzman, W., Levine, A.J., Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1 (1981), 101–110.
190. Padgett, B.L., Walker, D.L., ZuRhein, G.M., Eckroade, R.J., Dessel, B.H., Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1 (1971), 1257–1260.
191. Pallas, D.C., Shahrik, L.K., Martin, B.L., Jaspers, S., Miller, T.B., Brautigan, D.L., Roberts, T.M., Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60 (1990), 167–176.
192. Pastrana, D.V., Tolstov, Y.L., Becker, J.C., Moore, P.S., Chang, Y., Buck, C.B., Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog., 5, 2009, e1000578.
193. Peden, K.W., Pipas, J.M., Simian virus 40 mutants with amino-acid substitutions near the amino terminus of large T antigen. Virus Genes 6 (1992), 107–118.
194. Peden, K.W., Spence, S.L., Tack, L.C., Cartwright, C.A., Srinivasan, A., Pipas, J.M., A DNA replication-positive mutant of simian virus 40 that is defective for transformation and the production of infectious virions. J. Virol. 64 (1990), 2912–2921.
195. Perera, D., Tilston, V., Hopwood, J.A., Barchi, M., Boot-Handford, R.P., Taylor, S.S., Bub1 maintains centromeric cohesion by activation of the spindle checkpoint. Dev. Cell 13 (2007), 566–579.
196. Pina-Oviedo, S., De Leon-Bojorge, B., Cuesta-Mejias, T., White, M.K., Ortiz-Hidalgo, C., Khalili, K., Del Valle, L., Glioblastoma multiforme with small cell neuronal-like component: association with human neurotropic JC virus. Acta Neuropathol. 111 (2006), 388–396.
197. Pipas, J.M., Common and unique features of T antigens encoded by the polyomavirus group. J. Virol. 66 (1992), 3979–3985.
198. Pipas, J.M., SV40: Cell transformation and tumorigenesis. Virology 384 (2009), 294–303.
199. Pipas, J.M., Peden, K.W., Nathans, D., Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T-antigen gene. Mol. Cell. Biol. 3 (1983), 203–213.
200. Porras, A., Bennett, J., Howe, A., Tokos, K., Bouck, N., Henglein, B., Sathyamangalam, S., Thimmapaya, B., Rundell, K., A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J. Virol. 70 (1996), 6902–6908.
201. Porras, A., Gaillard, S., Rundell, K., The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts. J. Virol. 73 (1999), 3102–3107.
202. Poulin, D.L., Kung, A.L., DeCaprio, J.A., p53 targets simian virus 40 large T antigen for acetylation by CBP. J. Virol. 78 (2004), 8245–8253.
203. Prisco, M., Santini, F., Baffa, R., Liu, M., Drakas, R., Wu, A., Baserga, R., Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J. Biol. Chem. 277 (2002), 32078–32085.
204. Quartin, R.S., Cole, C.N., Pipas, J.M., Levine, A.J., The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J. Virol. 68 (1994), 1334–1341.
205. Querido, E., Marcellus, R.C., Lai, A., Charbonneau, R., Teodoro, J.G., Ketner, G., Branton, P.E., Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71 (1997), 3788–3798.
206. Rassoulzadegan, M., Perbal, B., Cuzin, F., Growth control in simian virus 40-transformed rat cells: temperature-independent expression of the transformed phenotype in tsA transformants derived by agar selection. J. Virol. 28 (1978), 1–5.
207. Rathi, A.V., Saenz Robles, M.T., Pipas, J.M., Enterocyte proliferation and intestinal hyperplasia induced by simian virus 40 T antigen require a functional J domain. J. Virol. 81 (2007), 9481–9489.
208. Rathi, A.V., Saenz Robles, M.T., Cantalupo, P.G., Whitehead, R.H., Pipas, J.M., Simian virus 40 T-antigen-mediated gene regulation in enterocytes is controlled primarily by the Rb-E2F pathway. J. Virol. 83 (2009), 9521–9531.
209. Ray, F.A., Kraemer, P.M., Iterative chromosome mutation and selection as a mechanism of complete transformation of human diploid fibroblasts by SV40 T antigen. Carcinogenesis 14 (1993), 1511–1516.
210. Ray, F.A., Peabody, D.S., Cooper, J.L., Cram, L.S., Kraemer, P.M., SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J. Cell. Biochem. 42 (1990), 13–31.
211. Ray, F.A., Meyne, J., Kraemer, P.M., SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblasts. Mutat. Res. 284 (1992), 265–273.
212. Reich, N.C., Oren, M., Levine, A.J., Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol. 3 (1983), 2143–2150.
213. Ren, L., Gonzalez, R., Xie, Z., Zhang, J., Liu, C., Li, J., Li, Y., Wang, Z., Kong, X., Yao, Y., Hu, Y., Qian, S., et al. WU and KI polyomavirus present in the respiratory tract of children, but not in immunocompetent adults. J. Clin. Virol. 43 (2008), 330–333.
214. Rodriguez-Viciana, P., Collins, C., Fried, M., Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc. Natl. Acad. Sci. USA 103 (2006), 19290–19295.
215. Rundell, K., Parakati, R., The role of the SV40 ST antigen in cell growth promotion and transformation. Semin. Cancer Biol. 11 (2001), 5–13.
216. Rushton, J.J., Jiang, D., Srinivasan, A., Pipas, J.M., Robbins, P.D., Simian virus 40 T antigen can regulate p53-mediated transcription independent of binding p53. J. Virol. 71 (1997), 5620–5623.
217. Sablina, A.A., Hahn, W.C., SV40 small T antigen and PP2A phosphatase in cell transformation. Cancer Metastasis Rev. 27 (2008), 137–146.
218. Saenz Robles, M.T., Pipas, J.M., T antigen transgenic mouse models. Semin. Cancer Biol. 19 (2009), 229–235.
219. Saenz Robles, M.T., Symonds, H., Chen, J., Van Dyke, T., Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol. Cell. Biol. 14 (1994), 2686–2698.
220. Sage, J., Mulligan, G.J., Attardi, L.D., Miller, A., Chen, S., Williams, B., Theodorou, E., Jacks, T., Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14 (2000), 3037–3050.
221. Samuelson, A.V., Narita, M., Chan, H.M., Jin, J., de Stanchina, E., McCurrach, M.E., Fuchs, M., Livingston, D.M., Lowe, S.W., p400 is required for E1A to promote apoptosis. J. Biol. Chem. 280 (2005), 21915–21923.
222. Sarikas, A., Xu, X., Field, L.J., Pan, Z.Q., The cullin7 E3 ubiquitin ligase: a novel player in growth control. Cell Cycle 7 (2008), 3154–3161.
223. Sarnow, P., Ho, Y.S., Williams, J., Levine, A.J., Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28 (1982), 387–394.
224. Sastre-Garau, X., Peter, M., Avril, M.F., Laude, H., Couturier, J., Rozenberg, F., Almeida, A., Boitier, F., Carlotti, A., Couturaud, B., Dupin, N., Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J. Pathol. 218 (2009), 48–56.
225. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., Howley, P.M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990), 1129–1136.
226. Schliekelman, M., Cowley, D.O., O'Quinn, R., Oliver, T.G., Lu, L., Salmon, E.D., Van Dyke, T., Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis. Cancer Res. 69 (2009), 45–54.
227. Segawa, K., Minowa, A., Sugasawa, K., Takano, T., Hanaoka, F., Abrogation of p53-mediated transactivation by SV40 large T antigen. Oncogene 8 (1993), 543–548.
228. Seif, R., Martin, R.G., Growth state of the cell early after infection with simian virus 40 determines whether the maintenance of transformation will be A-gene dependent or independent. J. Virol. 31 (1979), 350–359.
229. Sell, C., Rubini, M., Rubin, R., Liu, J.P., Efstratiadis, A., Baserga, R., Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90 (1993), 11217–11221.
230. Sellers, W.R., Novitch, B.G., Miyake, S., Heith, A., Otterson, G.A., Kaye, F.J., Lassar, A.B., Kaelin, W.G. Jr., Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12 (1998), 95–106.
231. Seo, G.J., Fink, L.H., O'Hara, B., Atwood, W.J., Sullivan, C.S., Evolutionarily conserved function of a viral microRNA. J. Virol. 82 (2008), 9823–9828.
232. Sharp, C.P., Norja, P., Anthony, I., Bell, J.E., Simmonds, P., Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J. Infect. Dis. 199 (2009), 398–404.
233. Sheppard, H.M., Corneillie, S.I., Espiritu, C., Gatti, A., Liu, X., New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen. Mol. Cell. Biol. 19 (1999), 2746–2753.
234. Shi, Y., Dodson, G.E., Shaikh, S., Rundell, K., Tibbetts, R.S., Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J. Biol. Chem. 280 (2005), 40195–40200.
235. Shuda, M., Feng, H., Kwun, H.J., Rosen, S.T., Gjoerup, O., Moore, P.S., Chang, Y., T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. USA 105 (2008), 16272–16277.
236. Shuda, M., Arora, R., Kwun, H.J., Feng, H., Sarid, R., Fernandez-Figueras, M.T., Tolstov, Y., Gjoerup, O., Mansukhani, M.M., Swerdlow, S.H., Chaudhary, P.M., Kirkwood, J.M., et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int. J. Cancer 125 (2009), 1243–1249.
237. Sihto, H., Kukko, H., Koljonen, V., Sankila, R., Bohling, T., Joensuu, H., Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J. Natl. Cancer Inst. 101 (2009), 938–945.
238. Simin, K., Wu, H., Lu, L., Pinkel, D., Albertson, D., Cardiff, R.D., Van Dyke, T., pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol., 2, 2004, E22.
239. Singhal, G., Kadeppagari, R.K., Sankar, N., Thimmapaya, B., Simian virus 40 large T overcomes p300 repression of c-Myc. Virology 377 (2008), 227–232.
240. Skoczylas, C., Fahrbach, K.M., Rundell, K., Cellular targets of the SV40 small-t antigen in human cell transformation. Cell Cycle 3 (2004), 606–610.
241. Skoczylas, C., Henglein, B., Rundell, K., PP2A-dependent transactivation of the cyclin A promoter by SV40 ST is mediated by a cell cycle-regulated E2F site. Virology 332 (2005), 596–601.
242. Sleigh, M.J., Topp, W.C., Hanich, R., Sambrook, J.F., Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell 14 (1978), 79–88.
243. Small, M.B., Gluzman, Y., Ozer, H.L., Enhanced transformation of human fibroblasts by origin-defective simian virus 40. Nature 296 (1982), 671–672.
244. Sontag, J.M., Sontag, E., Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation. Cell. Mol. Life Sci. 63 (2006), 2979–2991.
245. Sontag, E., Fedorov, S., Kamibayashi, C., Robbins, D., Cobb, M., Mumby, M., The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75 (1993), 887–897.
246. Sontag, E., Sontag, J.M., Garcia, A., Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J. 16 (1997), 5662–5671.
247. Sotillo, E., Garriga, J., Kurimchak, A., Grana, X., Cyclin E and SV40 small T antigen cooperate to bypass quiescence and contribute to transformation by activating CDK2 in human fibroblasts. J. Biol. Chem. 283 (2008), 11280–11292.
248. Srinivasan, A., Peden, K.W., Pipas, J.M., The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J. Virol. 63 (1989), 5459–5463.
249. Srinivasan, A., McClellan, A.J., Vartikar, J., Marks, I., Cantalupo, P., Li, Y., Whyte, P., Rundell, K., Brodsky, J.L., Pipas, J.M., The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol. Cell. Biol. 17 (1997), 4761–4773.
250. Stewart, N., Bacchetti, S., Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 180 (1991), 49–57.
251. Stracker, T.H., Carson, C.T., Weitzman, M.D., Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418 (2002), 348–352.
252. Stubdal, H., Zalvide, J., DeCaprio, J.A., Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J. Virol. 70 (1996), 2781–2788.
253. Stubdal, H., Zalvide, J., Campbell, K.S., Schweitzer, C., Roberts, T.M., DeCaprio, J.A., Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17 (1997), 4979–4990.
254. Sullivan, C.S., Pipas, J.M., T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol. Mol. Biol. Rev. 66 (2002), 179–202.
255. Sullivan, C.S., Cantalupo, P., Pipas, J.M., The molecular chaperone activity of simian virus 40 large T antigen is required to disrupt Rb-E2F family complexes by an ATP-dependent mechanism. Mol. Cell. Biol. 20 (2000), 6233–6243.
256. Sullivan, C.S., Tremblay, J.D., Fewell, S.W., Lewis, J.A., Brodsky, J.L., Pipas, J.M., Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40. Mol. Cell. Biol. 20 (2000), 5749–5757.
257. Sullivan, C.S., Baker, A.E., Pipas, J.M., Simian virus 40 infection disrupts p130-E2F and p107-E2F complexes but does not perturb pRb-E2F complexes. Virology 320 (2004), 218–228.
258. Sullivan, C.S., Grundhoff, A.T., Tevethia, S., Pipas, J.M., Ganem, D., SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435 (2005), 682–686.
259. Sullivan, C.S., Sung, C.K., Pack, C.D., Grundhoff, A., Lukacher, A.E., Benjamin, T.L., Ganem, D., Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Virology 387 (2009), 157–167.
260. Sweet, B.H., Hilleman, M.R., The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med. 105 (1960), 420–427.
261. Symonds, H.S., McCarthy, S.A., Chen, J., Pipas, J.M., Van Dyke, T., Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant. Mol. Cell. Biol. 13 (1993), 3255–3265.
262. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., Van Dyke, T., p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78 (1994), 703–711.
263. Tan, C.S., Dezube, B.J., Bhargava, P., Autissier, P., Wuthrich, C., Miller, J., Koralnik, I.J., Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J. Infect. Dis. 199 (2009), 881–888.
264. Tevethia, M.J., Bonneau, R.H., Griffith, J.W., Mylin, L., A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice. J. Virol. 71 (1997), 8157–8166.
265. Tevethia, M.J., Lacko, H.A., Kierstead, T.D., Thompson, D.L., Adding an Rb-binding site to an N-terminally truncated simian virus 40 T antigen restores growth to high cell density, and the T common region in trans provides anchorage-independent growth and rapid growth in low serum concentrations. J. Virol. 71 (1997), 1888–1896.
266. Tiemann, F., Deppert, W., Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency. Oncogene 9 (1994), 1907–1915.
267. Tiemann, F., Deppert, W., Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J. Virol. 68 (1994), 2869–2878.
268. Todaro, G.J., Green, H., Swift, M.R., Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science 153 (1966), 1252–1254.
269. Tolstov, Y.L., Pastrana, D.V., Feng, H., Becker, J.C., Jenkins, F.J., Moschos, S., Chang, Y., Buck, C.B., Moore, P.S., Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer 125 (2009), 1250–1256.
270. Touze, A., Gaitan, J., Maruani, A., Le Bidre, E., Doussinaud, A., Clavel, C., Durlach, A., Aubin, F., Guyetant, S., Lorette, G., Coursaget, P., Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg. Infect. Dis. 15 (2009), 960–962.
271. Trowbridge, P.W., Frisque, R.J., Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J. Neurovirol. 1 (1995), 195–206.
272. Turk, B., Porras, A., Mumby, M.C., Rundell, K., Simian virus 40 small-t antigen binds two zinc ions. J. Virol. 67 (1993), 3671–3673.
273. Tworkowski, K.A., Chakraborty, A.A., Samuelson, A.V., Seger, Y.R., Narita, M., Hannon, G.J., Lowe, S.W., Tansey, W.P., Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc. Proc. Natl. Acad. Sci. USA 105 (2008), 6103–6108.
274. Vago, L., Cinque, P., Sala, E., Nebuloni, M., Caldarelli, R., Racca, S., Ferrante, P., Trabottoni, G., Costanzi, G., JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 12 (1996), 139–146.
275. Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., Rutgeerts, P., Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 353 (2005), 362–368.
276. Varga, E., Kiss, M., Szabo, K., Kemeny, L., Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas. Br. J. Dermatol. 161 (2009), 930–932.
277. Wang, H.G., Rikitake, Y., Carter, M.C., Yaciuk, P., Abraham, S.E., Zerler, B., Moran, E., Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67 (1993), 476–488.
278. Watanabe, G., Howe, A., Lee, R.J., Albanese, C., Shu, I.W., Karnezis, A.N., Zon, L., Kyriakis, J., Rundell, K., Pestell, R.G., Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93 (1996), 12861–12866.
279. Werness, B.A., Levine, A.J., Howley, P.M., Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990), 76–79.
280. Wetzels, C.T., Hoefnagel, J.G., Bakkers, J.M., Dijkman, H.B., Blokx, W.A., Melchers, W.J., Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS ONE, 4, 2009, e4958.
281. White, M.K., Gordon, J., Reiss, K., Del Valle, L., Croul, S., Giordano, A., Darbinyan, A., Khalili, K., Human polyomaviruses and brain tumors. Brain Res. Brain Res. Rev. 50 (2005), 69–85.
282. Whyte, P., Buchkovich, K.J., Horowitz, J.M., Friend, S.H., Raybuck, M., Weinberg, R.A., Harlow, E., Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334 (1988), 124–129.
283. Woods, C., LeFeuvre, C., Stewart, N., Bacchetti, S., Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53. Oncogene 9 (1994), 2943–2950.
284. Wu, X., Avni, D., Chiba, T., Yan, F., Zhao, Q., Lin, Y., Heng, H., Livingston, D., SV40 T antigen interacts with Nbs1 to disrupt DNA replication control. Genes Dev. 18 (2004), 1305–1316.
285. Xiao, A., Wu, H., Pandolfi, P.P., Louis, D.N., Van Dyke, T., Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1 (2002), 157–168.
286. Xu, X., Sarikas, A., Dias-Santagata, D.C., Dolios, G., Lafontant, P.J., Tsai, S.C., Zhu, W., Nakajima, H., Nakajima, H.O., Field, L.J., Wang, R., Pan, Z.Q., The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol. Cell 30 (2008), 403–414.
287. Yaciuk, P., Carter, M.C., Pipas, J.M., Moran, E., Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol. Cell. Biol. 11 (1991), 2116–2124.
288. Yang, S.I., Lickteig, R.L., Estes, R., Rundell, K., Walter, G., Mumby, M.C., Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 11 (1991), 1988–1995.
289. Yang, C.S., Xin, H.W., Kelley, J.B., Spencer, A., Brautigan, D.L., Paschal, B.M., Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions. Mol. Cell. Biol. 27 (2007), 3390–3404.
290. Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W.C., Stukenberg, P.T., Shenolikar, S., Uchida, T., Counter, C.M., Nevins, J.R., et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6 (2004), 308–318.
291. Yew, P.R., Berk, A.J., Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357 (1992), 82–85.
292. Yu, Y., Alwine, J.C., Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J. Virol. 82 (2008), 4521–4526.
293. Yu, J., Boyapati, A., Rundell, K., Critical role for SV40 small-t antigen in human cell transformation. Virology 290 (2001), 192–198.
294. Yu, Y., Kudchodkar, S.B., Alwine, J.C., Effects of simian virus 40 large and small tumor antigens on mammalian target of rapamycin signaling: small tumor antigen mediates hypophosphorylation of eIF4E-binding protein 1 late in infection. J. Virol. 79 (2005), 6882–6889.
295. Yuan, H., Veldman, T., Rundell, K., Schlegel, R., Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J. Virol. 76 (2002), 10685–10691.
296. Zalvide, J., DeCaprio, J.A., Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15 (1995), 5800–5810.
297. Zalvide, J., Stubdal, H., DeCaprio, J.A., The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Mol. Cell. Biol. 18 (1998), 1408–1415.
298. Zerrahn, J., Knippschild, U., Winkler, T., Deppert, W., Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J. 12 (1993), 4739–4746.
299. Zhao, J.J., Gjoerup, O.V., Subramanian, R.R., Cheng, Y., Chen, W., Roberts, T.M., Hahn, W.C., Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3 (2003), 483–495.
300. Zhao, X., Madden-Fuentes, R.J., Lou, B.X., Pipas, J.M., Gerhardt, J., Rigell, C.J., Fanning, E., Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J. Virol. 82 (2008), 5316–5328.
301. Zhu, J.Y., Abate, M., Rice, P.W., Cole, C.N., The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J. Virol. 65 (1991), 6872–6880.
302. Zhu, J., Rice, P.W., Gorsch, L., Abate, M., Cole, C.N., Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen. J. Virol. 66 (1992), 2780–2791.
303. Zhu, J., Wang, H., Bishop, J.M., Blackburn, E.H., Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96 (1999), 3723–3728.